These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 35784565)

  • 1. Role of Glucagon and Its Receptor in the Pathogenesis of Diabetes.
    Jia Y; Liu Y; Feng L; Sun S; Sun G
    Front Endocrinol (Lausanne); 2022; 13():928016. PubMed ID: 35784565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of glucagon and insulin action reveals a role for the GLP-1 receptor in endogenous glucose production.
    Jun LS; Millican RL; Hawkins ED; Konkol DL; Showalter AD; Christe ME; Michael MD; Sloop KW
    Diabetes; 2015 Mar; 64(3):819-27. PubMed ID: 25288673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The essential role of glucagon in the pathogenesis of diabetes mellitus.
    Unger RH; Orci L
    Lancet; 1975 Jan; 1(7897):14-6. PubMed ID: 46337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic effects of combined glucagon receptor antagonism and glucagon-like peptide-1 receptor agonism in high fat fed mice.
    Franklin ZJ; Lafferty RA; Flatt PR; McShane LM; O'Harte FPM; Irwin N
    Biochimie; 2022 Aug; 199():60-67. PubMed ID: 35439540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon is the key factor in the development of diabetes.
    Lee YH; Wang MY; Yu XX; Unger RH
    Diabetologia; 2016 Jul; 59(7):1372-1375. PubMed ID: 27115412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The contribution of hyperglycemic hormones to the pathogenesis of diabetes mellitus.
    Sperling MA
    Am J Dis Child; 1977 Oct; 131(10):1145-9. PubMed ID: 910769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon as a target for the treatment of Type 2 diabetes.
    Sloop KW; Michael MD; Moyers JS
    Expert Opin Ther Targets; 2005 Jun; 9(3):593-600. PubMed ID: 15948676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor 21 (FGF21) and glucagon-like peptide 1 contribute to diabetes resistance in glucagon receptor-deficient mice.
    Omar BA; Andersen B; Hald J; Raun K; Nishimura E; Ahrén B
    Diabetes; 2014 Jan; 63(1):101-10. PubMed ID: 24062250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of glucagon signaling prevents or reverses diabetes onset only if residual β-cells persist.
    Damond N; Thorel F; Moyers JS; Charron MJ; Vuguin PM; Powers AC; Herrera PL
    Elife; 2016 Apr; 5():. PubMed ID: 27092792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GLP-2 receptor signaling controls circulating bile acid levels but not glucose homeostasis in Gcgr
    Patel A; Yusta B; Matthews D; Charron MJ; Seeley RJ; Drucker DJ
    Mol Metab; 2018 Oct; 16():45-54. PubMed ID: 29937214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel DPP IV-resistant C-terminally extended glucagon analogue exhibits weight-lowering and diabetes-protective effects in high-fat-fed mice mediated through glucagon and GLP-1 receptor activation.
    Lynch AM; Pathak N; Pathak V; O'Harte FP; Flatt PR; Irwin N; Gault VA
    Diabetologia; 2014 Sep; 57(9):1927-36. PubMed ID: 24962667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic and glucagon-like peptide-1-mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors.
    Sloop KW; Cao JX; Siesky AM; Zhang HY; Bodenmiller DM; Cox AL; Jacobs SJ; Moyers JS; Owens RA; Showalter AD; Brenner MB; Raap A; Gromada J; Berridge BR; Monteith DK; Porksen N; McKay RA; Monia BP; Bhanot S; Watts LM; Michael MD
    J Clin Invest; 2004 Jun; 113(11):1571-81. PubMed ID: 15173883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational identification of novel natural inhibitors of glucagon receptor for checking type II diabetes mellitus.
    Grover S; Dhanjal JK; Goyal S; Grover A; Sundar D
    BMC Bioinformatics; 2014; 15 Suppl 16(Suppl 16):S13. PubMed ID: 25521597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon Potentiates Insulin Secretion Via β-Cell GCGR at Physiological Concentrations of Glucose.
    Zhang Y; Han C; Zhu W; Yang G; Peng X; Mehta S; Zhang J; Chen L; Liu Y
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon receptor knockout prevents insulin-deficient type 1 diabetes in mice.
    Lee Y; Wang MY; Du XQ; Charron MJ; Unger RH
    Diabetes; 2011 Feb; 60(2):391-7. PubMed ID: 21270251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon receptor inhibition normalizes blood glucose in severe insulin-resistant mice.
    Okamoto H; Cavino K; Na E; Krumm E; Kim SY; Cheng X; Murphy AJ; Yancopoulos GD; Gromada J
    Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2753-2758. PubMed ID: 28115707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual elimination of the glucagon and GLP-1 receptors in mice reveals plasticity in the incretin axis.
    Ali S; Lamont BJ; Charron MJ; Drucker DJ
    J Clin Invest; 2011 May; 121(5):1917-29. PubMed ID: 21540554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biochemical bases of pathogenesis in diabetes mellitus].
    Iudaev NA
    Ter Arkh; 1977; 49(5):6-11. PubMed ID: 877897
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of glucagon in the pathogenesis of diabetes: the status of the controversy.
    Unger RH
    Metabolism; 1978 Nov; 27(11):1691-709. PubMed ID: 360007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dietary carbohydrates on insulin and glucagon receptors in a new model of noninsulin-dependent diabetes-SHR/N-corpulent rat.
    Bhathena SJ; Kennedy BW; Jones J; Smith PM; Michaelis OE; Carswell N; Hansen CT; Voyles NR; Recant L
    Proc Soc Exp Biol Med; 1989 Oct; 192(1):66-71. PubMed ID: 2552455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.